Salemonline Journal

Press Release

Burns Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Burns pipeline constitutes 12+ key companies continuously working towards developing 12+ Burns treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read Full Article

Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Escient Pharma, GlaxoSmithKline, Mirum Pharma, Albireo, Regeneron Pharma

The Cholestatic Pruritus Market Forecast report offers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the 7MM. Cholestatic

Read Full Article

Dermatomyositis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | AstraZeneca Plc., Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus

The Dermatomyositis Market was valued approximately USD 230 million in 2022 and the report offers an in-depth understanding of the Dermatomyositis, historical and forecasted epidemiology as well as the Dermatomyositis

Read Full Article

Diffuse Cutaneous Systemic Sclerosis Market to Exhibit Rapid Growth Rate During the Forecast Period (2024-2034), Investigates DelveInsight | Kyowa Hakko Kirin, Kadmon Corporation, Sanofi, Emerald

The Diffuse Cutaneous Systemic Sclerosis Market Forecast report offers an in-depth understanding of the Diffuse Cutaneous Systemic Sclerosis, historical and forecasted epidemiology as well as the Diffuse Cutaneous Systemic Sclerosis

Read Full Article

Cutaneous Squamous Cell Carcinoma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Incyte Crp, Merck Sharp, Regeneron Pharma, Replimune Inc

The Cutaneous Squamous Cell Carcinoma Market Forecast report offers an in-depth understanding of the Cutaneous Squamous Cell Carcinoma, historical and

Read Full Article

Chronic Wounds Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards

Read Full Article

The 3D Urology and Prostate Clinics Introduce Groundbreaking Non-Surgical Prostate Treatments For Revolutionizing Prostate Disease Care

The 3D Urology and Prostate Clinics introduced a holistic approach to treating prostate and genitourinary conditions with their 3D Natural

Read Full Article

Happy Breathing Launches its Easy-to-Use Baby Nasal Aspirator with Medical-grade Suction

Happy Breathing, a pioneering company in pediatric healthcare, is set to revolutionize the way parents care for their infants with

Read Full Article

Celiac Disease Pipeline Analysis 2024: Clinical Trials, FDA Approvals, Emerging Therapies, ROA, MOA and Treatment Outlook by DelveInsight | Amgen, AMYRA Biotec, Equillium Bio, Chugai Pharmaceutical

Celiac Disease Pipeline As per DelveInsight’s assessment, globally, Celiac Disease pipeline constitutes 25+ key companies continuously working towards developing 25+

Read Full Article

Diabetic Kidney Disease Market is anticipated to Grow at a CAGR of ~6.5% by 2034, analyzes DelveInsight | Boehringer Ingelheim, Daiichi Sankyo, ProKidney, Chinook Therapeutics, AbbVie,Inversago Pharma

Diabetic Kidney Disease Market The dynamics of the diabetic kidney disease market are anticipated to change in the coming years

Read Full Article